Tyrosine phosphatase inhibition enhances neurotrophin potency and rescues nigrostriatal neurons in adult rats

Experimental Neurology

Volumn 178, Issue 2, 2002, Pages 259-267

  Lu, X ^a   Maysinger, D ^b   Hagg, Theo ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c University of Louisville School of Medicine   (United States)

Author keywords

Brain derived neurotrophic factor; Cell survival; Dopaminergic; Neurotrophic factor receptor; Parkinson's disease; Protein tyrosine phosphatase; Substantia nigra; TrkB; Tyrosine hydroxylase; Tyrosine kinase

Indexed keywords

NEUROTROPHIC FACTOR; NEUROTROPHIN; PERVANADATE; POLYVINYL ALCOHOL; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENZYME INHIBITION; FEMALE; NERVE FIBER TRANSECTION; NERVE TRANSECTION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

EID: 0036938257     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.8042     Document Type: Article

References (57)

1. Altar, C. A., J. A. Siuciak, P. Wright, N. Y. Ip, R. M. Lindsay, and S. J. Wiegand. 1994. In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. Eur. J. Neurosci. 6: 1389-1405.
2. Altar, C. A., N. Cai, T. Bliven, M. Juhasz, J. M. Conner, A. L. Acheson, R. M. Lindsay, and S. J. Wiegand. 1997. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389: 856-860.
3. Araki, T., M. Yamada, H. Ohnishi, S. Sano, T. Uetsuki, and H. Hatanaka. 2000. Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons. J. Neurochem. 74: 659-668.
4. Arregui, C. O., J. Balsamo, and J. Lilien. 2000. Regulation of signaling by protein-tyrosine phosphatases: Potential roles in the nervous system. Neurochem. Res. 25: 95-105.
5. Beck, K. D., J. Valverde, T. Alexi, K. Poulsen, B. Moffat, R. A. Vandlen, A. Rosenthal, and F. Hefti. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341.
6. Benisty, S., F. Boissiere, B. Faucheux, Y. Agid, and E. C. Hirsch. 1998. trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: An in situ hybridization study. Neuroscience 86: 813-826.
7. Boulanger, L. M., P. J. Lombroso, A. Raghunathan, M. J. During, P. Wahle, and J. R. Naegele. 1995. Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci. 15: 1532-1544.
8. Burke, T. R., Jr., and Z. Y. Zhang. 1998. Protein-tyrosine phosphatases: Structure, mechanism, and inhibitor discovery. Biopolymers 47: 225-241.
9. Conner, J. M., J. C. Lauterborn, Q. Yan, C. M. Gall, and S. Varon. 1997. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci. 17: 2295-2313.
10. Dluzen, D. E., G. M. Story, K. Xu, J. Kucera, and J. M. Walro. 1999. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp. Neurol. 160: 500-507.
11. Doroshenko, P. 1998. Pervanadate inhibits volume-sensitive chloride current in bovine chromaffin cells. Pflugers Arch. 435: 303-309.
12. Emsley, J. G., X. Lu, and T. Hagg. 2001. Retrograde tracing techniques influence reported death rates of adult rat nigrostriatal neurons. Exp. Neurol. 168: 425-433.
13. Frim, D. M., T. A. Uhler, W. R. Galpern, M. F. Beal, X. O. Breakefield, and O. Isacson. 1994. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA 91: 5104-5108.
14. Grafstein, B. 1975. The nerve cell body response to axotomy. Exp. Neurol. 48: 32-51.
15. Hagg, T., and S. Varon. 1993. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA 90: 6315-6319.
16. Hagg, T. 1997. Neurotrophic factors. In Encyclopedia of Human Biology (R. Dulbecco, Ed.), Vol. 6, pp. 223-234. Academic Press, San Diego.
17. Hagg, T. 1998. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. Neurol. 149: 183-192.
18. Huang, E. J., and L. F. Reichardt. 2001. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 24: 677-736.
19. Hunter, T. 1995. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
20. Ip, N. Y., and G. D. Yancopoulos. 1996. The neurotrophins and CNTF: Two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19: 491-515.
21. Kaplan, D. R., and F. D. Miller. 2000. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10: 381-391.
22. Keilhack, H., M. Muller, S. A. Bohmer, C. Frank, K. M. Weidner, W. Birchmeier, T. Ligensa, A. Berndt, H. Kosmehl, B. Gunther, T. Muller, C. Birchmeier, and F. D. Bohmer. 2001. Negative regulation of Ros receptor tyrosine kinase signaling: An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J. Cell Biol. 152: 325-334.
23. Kobayashi, N. R., D. P. Fan, K. M. Giehl, A. M. Bedard, S. J. Wiegand, and W. Tetzlaff. 1997. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talphal-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17: 9583-9595.
24. Kordower, J. H., M. E. Emborg, J. Bloch, S. Y. Ma, Y. Chu, L. Leventhal, J. McBride, E. Y. Chen, S. Palfi, B. Z. Roitberg, W. D. Brown, J. E. Holden, R. Pyzalski, M. D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon, and P. Aebischer. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290: 767-773.
25. Lapchak, P. A., K. D. Beck, D. M. Araujo, I. Irwin, J. W. Langston, and F. Hefti. 1993. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53: 639-650.
26. Lau, Y. S., R. Hao, Y. K. Fung, L. S. Fu, J. F. Bishop, R. F. Pfeiffer, and M. M. Mouradian. 1998. Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor. Neurochem. Res. 23: 525-532.
27. Levi-Montalcini, R. 1987. The nerve growth factor 35 years later. Science 237: 1154-1162.
28. Li, J., G. Elberg, and Y. Shechter. 1996. Phenylarsine oxide and vanadate: Apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes. Biochim. Biophys. Acta 1312: 223-230.
29. Lombroso, P. J., J. R. Naegele, E. Sharma, and M. Lerner. 1993. A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J. Neurosci. 13: 3064-3074.
30. Lu, X., and T. Hagg. 1997. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. J. Comp. Neurol. 388: 484-494.
31. Naegele, J. R., and P. J. Lombroso. 1994. Protein tyrosine phosphatases in the nervous system. Crit. Rev. Neurobiol. 9: 105-114.
32. Neel, B. G., and N. K. Tonks. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9: 193-204.
33. Nishio, T., S. Furukawa, I. Akiguchi, and N. Sunohara. 1998. Medial nigral dopamine neurons have rich neurotrophin support in humans. NeuroReport 9: 2847-2851.
34. Numan, S., and K. B. Seroogy. 1999. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: A double-label in situ hybridization study. J. Comp. Neurol. 403: 295-308.
35. Okada, N., K. Wada, B. A. Goldsmith, and S. Koizumi. 1996. SHP-2 is involved in neurotrophin signaling. Biochem. Biophys. Res. Commun. 229: 607-611.
36. Park, J., and A. Y. Liu. 2000. Pervanadate induces the hyperphosphorylation but not the activation of human heat shock factor 1. J. Cell Physiol. 185: 348-357.
37. Patapoutian, A., and L. F. Reichardt. 2001. Trk receptors: Mediators of neurotrophin action. Curr. Opin. Neurobiol. 11: 272-280.
38. Posner, B. I., R. Faure, J. W. Burgess, A. P. Bevan, D. Lachance, G. Zhang-Sun, I. G. Fantus, J. B. Ng, D. A. Hall, and B. S. Lum. 1994. Peroxovanadium compounds: A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269: 4596-4604.
39. Ruff, S. J., K. Chen, and S. Cohen. 1997. Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J. Biol. Chem. 272: 1263-1267.
40. Sahin, M., J. J. Dowling, and S. Hockfield. 1995. Seven protein tyrosine phosphatases are differentially expressed in the developing rat brain. J. Comp. Neurol. 351: 617-631.
41. Sekar, N., J. Li, and Y. Shechter. 1996. Vanadium salts as insulin substitutes: Mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev. Biochem. Mol. Biol. 31: 339-359.
42. Seroogy, K. B., K. H. Lundgren, T. M. Tran, K. M. Guthrie, P. J. Isackson, and C. M. Gall. 1994. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp Neurol. 342: 321-334.
43. Shintani, T., N. Maeda, and M. Noda. 2001. Receptor-like protein tyrosine phosphatase gamma (RPTPgamma), but not PT-Pzeta/RPTPbeta, inhibits nerve-growth-factor-induced neurite outgrowth in PC12D cells. Dev. Neurosci. 23: 55-69.
44. Snyder, S. E., J. Li, P. E. Schauwecker, T. H. McNeill, and S. R. Salton. 1996. Comparison of RPTP zeta/beta, phosphacan, and trkB mRNA expression in the developing and adult rat nervous system and induction of RPTP zeta/beta and phosphacan mRNA following brain injury. Brain Res. Mol. Brain Res. 40: 79-96.
45. Sofroniew, M. V., C. L. Howe, and W. C. Mobley. 2001. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24: 1217-1281.
46. Tiganis, T., B. E. Kemp, and N. K. Tonks. 1999. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J. Biol. Chem. 274: 27768-27775.
47. Tisi, M. A., Y. Xie, T. T. Yeo, and F. M. Longo. 2000. Downregulation of LAR tyrosine phosphatase prevents apoptosis and augments NGF-induced neurite outgrowth. J. Neurobiol. 42: 477-486.
48. Tomac, A., E. Lindqvist, L. F. Lin, S. O. Ogren, D. Young, B. J. Hoffer, and L. Olson. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339.
49. Tonks, N. K. 1996. Protein tyrosine phosphatases and the control of cellular signaling responses. Adv. Pharmacol. 36: 91-119.
50. Tonks, N. K., and B. G. Neel. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13: 182-195.
51. Treanor, J. J., L. Goodman, F. de Sauvage, D. M. Stone, K. T. Poulsen, C. D. Beck, C. Gray, M. P. Armanini, R. A. Pollock, F. Hefti, H. S. Phillips, A. Goddard, M. W. Moore, A. Buj-Bello, A. M. Davies, N. Asai, M. Takahashi, R. Vandlen, C. E. Henderson, and A. Rosenthal. 1996. Characterization of a multi-component receptor for GDNF. Nature 382: 80-83.
52. Trupp, M., N. Belluardo, H. Funakoshi, and C. F. Ibanez. 1997. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17: 3554-3567.
53. Vambutas, V., D. R. Kaplan, M. A. Sells, and J. Chernoff. 1995. Nerve growth factor stimulates tyrosine phosphorylation and activation of Src homology-containing protein-tyrosine phosphatase 1 in PC12 cells. J. Biol. Chem. 270: 25629-25633.
54. Van Vactor, D. 1998. Protein tyrosine phosphatases in the developing nervous system. Curr. Opin. Cell Biol. 10: 174-181.
55. Venero, J. L., M. L. Vizuete, M. Revuelta, C. Vargas, J. Cano, and A. Machado. 2000. Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle. Exp. Neurol. 161: 38-48.
56. Zhang, J. S., and F. M. Longo. 1995. LAR tyrosine phosphatase receptor: Alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats. J. Cell Biol. 128: 415-431.
57. Zhang, Z. Y. 1997. Structure, mechanism, and specificity of protein-tyrosine phosphatases. Curr. Top. Cell Regul. 35: 21-68.